title: [Economic prerequisites of active influenza prevention].
abstract: Influenza and other acute infections of the upper respiratory tract are characterized by a high morbidity and mortality. As a result, they entail not only human but also economic consequences. A typical treatment is nonspecific and conservative. It consists of treatment with nonsteroid antiinflammatory drugs, antitussive drugs, hydratation, etc. Influenza is very often associated with complications especially in high risk groups (children, the elderly, chronically-ill people). The cost of treatment increases because of raising costs of pharmacotherapy and the increased absence from work. Vaccination is a safe and morbidity-diminishing method.
authors.affiliation: Katedry i Zakładu Farmakologii i Terapii Akademii Medycznej w Bydgoszczy. ggrzesk@aci.amb.bydgoszcz.pl
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Grześk
authors.forename: Andrzej
authors.initials: A
authors.lastname: Gałaj
authors.forename: Piotr
authors.initials: P
authors.lastname: Korbal
authors.forename: Anna
authors.initials: A
authors.lastname: Durmowicz
authors.forename: Leszek
authors.initials: L
authors.lastname: Szadujkis-Szadurski
authors.forename: Danuta
authors.initials: D
authors.lastname: Borys
authors.forename: Elzbieta
authors.initials: E
authors.lastname: Grześk
mesh_terms: D000367:Age Factors; D000368:Aged; D002648:Child; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D016527:Drug Costs; D017048:Health Care Costs; D006801:Humans; D007252:Influenza Vaccines / Q000627:therapeutic use*; D007251:Influenza, Human / Q000150:complications / Q000191:economics* / Q000453:epidemiology / Q000517:prevention & control*; D011044:Poland / Q000453:epidemiology; D011314:Preventive Health Services; D012141:Respiratory Tract Infections / Q000191:economics / Q000517:prevention & control; D012307:Risk Factors
chemical_list: D007252:Influenza Vaccines